Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Mar 23, 2010

Premium

Complete Genomics has appointed Mark Sutherland as senior vice president of business development. Among his highest priorities will be working more closely with large pharmaceutical companies and the National Institutes of Health. He will also help the company open satellite genome centers in other countries.

Sutherland comes to Complete Genomics from GenVault, where he held the same position. Prior to that, he was vice president of strategic alliances for the Discovery Systems business unit of GE Healthcare, and before that, vice president of genomics for Amersham Biosciences. Previously, he had various sales and marketing management roles at Molecular Dynamics and Applied Biosystems. Sutherland holds a BS in chemistry from Stanford University.


Shankar Balasubramanian has been named Innovator of the Year by the UK's Biotechnology and Biological Sciences Research Council, in recognition of his work on the sequencing technology that was later commercialized by Solexa (now part of Illumina). He received a £10,000 ($15,000) award. Balasubramanian is a professor at the University of Cambridge and a co-founder of Solexa.

The Scan

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.